Monday, October 6, 2014

Biogen Idec focuses on the patient and sustainability in manufacturing

At one point in time, it was thought that drug substance was one of the most important parts of drug manufacturing. But BioProcess International keynote speaker John G. Cox, Executive Vice President, Pharmaceutical Operations & Technology at Biogen Idec believes that one of the most important parts of bioprocessing is looking at the patient and providing the drug in a way that is easy for the patient to use.

John also provides insights on how  Biogen Idec isn't only looking at the way they develop drugs for patients - they're also looking at how they develop drugs and finding sustainable ways to manufacture drugs.  As they expand and build, buildings are outfitted drive sustainability.

John will be joining us on Tuesday, October 21 to present the keynote session Delivering on a Global Biopharmaceutical Portfolio: Biogen Idec’s Strategy for Success through Innovations in R&D, Protein Development and Manufacturing.  For more information on this session and the rest of the program, download the agenda.  

As a reader of this blog, when you register to join us and mention code BPI14BLOG, Looking for options with your registration?  Not only do we have the full pass - but we also have a keynote and exhibit hall pass.  Find out more here.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment